MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.

Publikation

MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.

Wissenschaftlicher Artikel/Review - 07.01.2022

Schwarz Ghil, Banerjee Gargi, Hostettler Isabel, Ambler Gareth, Seiffge David J, Ozkan Hatice, Browning Simone, Simister Robert J, Wilson Duncan, Cohen Hannah, Yousry Tarek A, Al-Shahi Salman Rustam, Lip Gregory Y H, Brown Martin M, Muir Keith, Houlden Henry, Jäger Rolf, Werring David J

Zitation

Schwarz G, Banerjee G, Hostettler I, Ambler G, Seiffge D, Ozkan H, Browning S, Simister R, Wilson D, Cohen H, Yousry T, Al-Shahi Salman R, Lip G, Brown M, Muir K, Houlden H, Jäger R, Werring D. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. Int J Stroke 2022; 18:85-94.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Int J Stroke 2022; 18

Veröffentlichungsdatum

07.01.2022

eISSN (Online)

1747-4949

Seiten

85-94

Kurzbeschreibung/Zielsetzung

Cerebral amyloid angiopathy (CAA), a common cause of intracerebral hemorrhage (ICH), is diagnosed using the Boston criteria including magnetic resonance imaging (MRI) biomarkers (cerebral microbleeds (CMBs) and cortical superficial siderosis (cSS). The simplified Edinburgh criteria include computed tomography (CT) biomarkers (subarachnoid extension (SAE) and finger-like projections (FLPs)). The underlying mechanisms and diagnostic accuracy of CT compared to MRI biomarkers of CAA are unknown.